{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:21:03Z","timestamp":1791958863039,"version":"4.3.4"},"reference-count":31,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,3,2]],"date-time":"2012-03-02T00:00:00Z","timestamp":1330646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contact Dermatitis"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:p><jats:bold>Background.<\/jats:bold> The warm und humid environment, friction and occlusion within shoes make the feet to a favorable body site to acquire allergic contact dermatitis.<\/jats:p><jats:p><jats:bold>Objectives.<\/jats:bold> To evaluate and compare patch test results in patients with suspected contact allergy of the feet with the results in those with concomitant involvement of the feet\/legs, feet\/hands, and all others tested (excluding secondary involvement of the feet in \u2018others\u2019), with regard to specific patterns of clinical data and patch test results.<\/jats:p><jats:p><jats:bold>Methods.<\/jats:bold> For the present cross\u2010sectional study, data were collected by the 59 participating centres of the Information Network of Departments of Dermatology in Germany, Austria, and Switzerland, including 102 209 patients patch\u2010tested between January 2001 and December 2010.<\/jats:p><jats:p><jats:bold>Results.<\/jats:bold> Allergens that were significantly over\u2010represented in the tested 2671 foot patients included potassium dichromate, colophonium, and <jats:italic>p<\/jats:italic>\u2010tert\u2010butylphenol\u2010formaldehyde resin. Among materials brought in by the patients, shoe pieces (27.5%), topical medications\/pharmaceutical products (24.4%) and cosmetics (16.8%) played a major role. The final diagnoses of vesicular and hyperkeratotic dermatitis, as well as psoriasis, were significantly more common among foot patients.<\/jats:p><jats:p><jats:bold>Conclusions.<\/jats:bold> Chromium compounds and adhesives were the most common causes of allergic contact dermatitis among our foot patients. Psoriasis should be considered, particularly when the hands are concomitantly affected.<\/jats:p>","DOI":"10.1111\/j.1600-0536.2012.02046.x","type":"journal-article","created":{"date-parts":[[2012,3,4]],"date-time":"2012-03-04T02:30:38Z","timestamp":1330828238000},"page":"271-278","source":"Crossref","is-referenced-by-count":55,"title":["Patch test characteristics of patients referred for suspected contact allergy of the feet\u2013retrospective 10\u2010year cross\u2010sectional study of the IVDK data"],"prefix":"10.1111","volume":"66","author":[{"given":"Lilla","family":"Landeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Uter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swen Malte","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,3,2]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.124697"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00631.x"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00692.x"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2007.00409.x"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2009.05.008"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-03827-3_41"},{"key":"e_1_2_9_8_2","first-page":"36","article-title":"Epidemiology of contact dermatitis. The Information Network of Departments of Dermatology (IVDK) in Germany.","volume":"8","author":"Uter W","year":"1998","journal-title":"Eur J Dermatol"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-03827-3_24"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2009.06787.x"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.5414\/DBP53107"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2004.00406.x"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1997.tb02435.x"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.34011"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2003.01717.x"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2003.38745"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2004.03039"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.22406.x"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2003.tb00453.x"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1988.tb02955.x"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1993.tb03428.x"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02208.x"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2007.06047"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01634989-199409000-00008"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2009.01628.x"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0916"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2011.01922.x"},{"key":"e_1_2_9_28_2","unstructured":"Directive 98\/8\/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market. Available at:http:\/\/eur\u2010lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:1998:123:0001:0063:EN:PDF[last accessed 11 May 2011]."},{"key":"e_1_2_9_29_2","unstructured":"2009\/251\/EC: Commission Decision of 17 March 2009 requiring Member States to ensure that products containing the biocide dimethylfumarate are not placed or made available on the market (notified under document number C(2009) 1723). Available at:http:\/\/eur\u2010lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2009:074:0032:0034:EN:PDF[last accessed 11 May 2011]."},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063356"},{"key":"e_1_2_9_31_2","unstructured":"StorrsF J.Shoe contact dermatitis.Available at:http:\/\/www.contactderm.org\/members\/FootDermatitis.pdf[last accessed 11 May 2011]."},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1998.tb05707.x"}],"container-title":["Contact Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0536.2012.02046.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0536.2012.02046.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T23:48:41Z","timestamp":1698709721000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0536.2012.02046.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,2]]},"references-count":31,"aliases":["10.1111\/j.1600-0536.2011.02046.x"],"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1111\/j.1600-0536.2012.02046.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0536.2012.02046.x","archive":["Portico"],"relation":{},"ISSN":["0105-1873","1600-0536"],"issn-type":[{"value":"0105-1873","type":"print"},{"value":"1600-0536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,2]]}}}